These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14417566)

  • 21. A study of the effectiveness of drug therapy in parkinsonism.
    KAPLAN HA; MACHOVER S; RABINER A
    J Nerv Ment Dis; 1954 May; 119(5):398-411. PubMed ID: 13192483
    [No Abstract]   [Full Text] [Related]  

  • 22. Preliminary study of a new anti-parkinson agent.
    DOSHAY LJ; CONSTABLE K; FROMER S
    Neurology; 1952; 2(3):233-43. PubMed ID: 14929300
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
    KIRCHHOF JK
    Nervenarzt; 1956 Oct; 27(10):447-53. PubMed ID: 13387960
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trials of transergan in the parkinsonian syndrome.
    ELIASSON S; TEJNING S
    Acta Med Scand; 1956 Jun; 154(5):375-9. PubMed ID: 13326279
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative measurement of therapy in paralysis agitans.
    AGATE FJ; DOSHAY LJ; CURTIS FK
    J Am Med Assoc; 1956 Feb; 160(5):352-4. PubMed ID: 13278202
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical observations on the relation of muscular rigidity and tremor in idiopathic paralysis agitans.
    PARK HW; HAJEK-NICHOLS N
    South Med J; 1959 Oct; 52():1246-8. PubMed ID: 14430469
    [No Abstract]   [Full Text] [Related]  

  • 27. Kemadrin, a new drug for treatment of Parkinsonian disease.
    LERNER PF
    J Nerv Ment Dis; 1956 Jan; 123(1):79-82. PubMed ID: 13346366
    [No Abstract]   [Full Text] [Related]  

  • 28. Antispasmodic compound 08958 in treatment of paralysis agitans.
    MAGEE KR; DEJONG RN
    J Am Med Assoc; 1953 Oct; 153(8):715-8. PubMed ID: 13096281
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cogentin, a medication with prolonged effect in parkinsonism].
    KELLER H
    Munch Med Wochenschr; 1960 Apr; 102():695-7. PubMed ID: 14405227
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lyseen (HH 212), a new substance for the treatment of extrapyramidal disorders and of muscle spasms of central and peripheral origin].
    SCHULZ HP
    Munch Med Wochenschr; 1961 May; 103():1066-8. PubMed ID: 13748916
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects.
    DOSHAY LJ; CONSTABLE K; AGATE FJ
    J Am Med Assoc; 1956 Feb; 160(5):348-51. PubMed ID: 13278201
    [No Abstract]   [Full Text] [Related]  

  • 32. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans.
    DOSHAY LJ
    J Am Med Assoc; 1956 Nov; 162(11):1031-4. PubMed ID: 13366700
    [No Abstract]   [Full Text] [Related]  

  • 33. NEW AND nonofficial remedies: cycrimine hydrochloride.
    J Am Med Assoc; 1955 Feb; 157(6):510-1. PubMed ID: 13221464
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacokinetics in parkinsonism].
    DE MAAR EW
    Geneeskd Gids; 1955 Aug; 33(17):339-48. PubMed ID: 13262536
    [No Abstract]   [Full Text] [Related]  

  • 35. Parsidol in the treatment of Parkinson's syndrome.
    SOBUE I; IVES ER
    Bull Los Angel Neuro Soc; 1956 Jun; 21(2):80-3. PubMed ID: 13329559
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activity of kemadrin on the symptoms of Parkinson's disease; comparison with other therapeutics].
    SIGWALD J
    Presse Med (1893); 1953 Jan; 61(7):127-8. PubMed ID: 13055735
    [No Abstract]   [Full Text] [Related]  

  • 37. The action of 267C (1-(1-piperidyl)-6-methyl-3-phenyl-3-heptanol hydrochloride) in Parkinson's disease.
    GIANVITO L; JACKSON I; MCGAVACK TH
    J Am Geriatr Soc; 1956 Aug; 4(8):793-6. PubMed ID: 13357272
    [No Abstract]   [Full Text] [Related]  

  • 38. [An observation on the treatment of Parkinson's syndrome; results with the new drug ParKS 12].
    HARDER A; PRELICZ T
    Schweiz Med Wochenschr; 1956 Mar; 86(13):335-8. PubMed ID: 13337189
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences in the treatment of parkinsonism & other extrapyramidal disorders].
    KONIG JK
    Medizinische; 1959 Feb; 4(9):388-9. PubMed ID: 13643481
    [No Abstract]   [Full Text] [Related]  

  • 40. [The benztropine methanesulfonate anti Parkinsonian agent].
    POCH GF
    Rev Asoc Med Argent; 1958 Sep; 72(9):357-60. PubMed ID: 13614757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.